Once-daily dolutegravir–based antiretroviral therapy amongst adults with advanced HIV disease receiving 1-month of daily rifapentine and isoniazid for TB preventive therapy and fluconazole for treatment of cryptococcal meningitis: results of a pharmacokinetic study (Open Forum Infectious Diseases, 2026)